Technology: High value manufacturing
-
Upload
bisgovuk -
Category
Technology
-
view
1.566 -
download
2
description
Transcript of Technology: High value manufacturing
Driving Innovation
Technology: High Value Manufacturing
Robin WilsonLead Technologist, High Value Manufacturing29th October 2009
UK Manufacturing StrategyProgress check - One Year On: NESTA, London
1
Driving Innovation
Pod 1 Pod 2 Pod 3 Pod 4 Pod 5
3.10-3.40
Global value chains - UKTI advanced engineeringDonald McNeil
Technology - High value manufacturing, Robin Wilson, Technology Strategy Board
Intangibles- Designing DemandDavid Godber, Design Council
Manufacturing Skills – an interactive session examining supply attraction and workforce development and then looking at skills for the future.Joanna Woolf, Cogent and Lynn Tomkins Semta
Low Carbon Industrial StrategyAdam Cartwright, Office for Low Emission Vehicles
3.50-4.10
UKTI – meet the companies exporting in and
Meet some of the companies who have been working successfully with TSB
Meet some of the companies where design has improved sales
Manufacturing the Future: Pat Langford, Director of Programmes, STEMNET will lead a discussion on promoting Manufacturing as an exciting and dynamic career choice. Meet a company who are working hard to inspire young people.
Meet companies who are operating successfully in low carbon markets
2
Driving Innovation
Who are the Technology Strategy Board
• We are a national body set up to invest in business innovation
• We are sponsored by Department of Business, Innovation and Skills (BIS – our hosts today)
• We come from business (and the public sector)About 100 people, >1200 years of business experience
• We work across business, universities and Government
• We are responsible for investing £1bn3
Driving Innovation
We support the full range of business
• We help strengthen the global competitive position of our leading businesses
• We identify and grow sectors and businesses with the capacity to become the best in the world
• We nurture the businesses that can succeed in the growth sectors of tomorrow
4
Driving Innovation
And we make choices
• We don’t pick winners, we pick sectors where UK businesses can thrive and support innovative companies in them
• We consider the size of the markets, the capability of the UK to address them and the timing
• And the difference our support would make
5
Driving Innovation
How we deliver
6
Driving Innovation
Technology Inspired Innovation
• We build capability in the underpinning areas that enable a sure and effective response to market needs– Advanced materials
– Bioscience
– Electronics, photonics and electrical systems
– Information and communication technologies
– High value manufacturing
– Nanotechnology
7
Driving Innovation
Our Tools for Prioritisation and Delivery
• Published Technology Strategies– To communicate funding priorities and rationale
• eg: High Value Manufacturing Strategy (Sept 2008)– To provide clear, consistent focus for funding applicants
• Competitions – collaborative R&D projects• eg: £24m High Value Mfg, launched January 2009
• Additional funding mechanisms• SBRI for R&D contracts (Government procurement)• Large (>£5m) CR&D Projects, assessed on individual basis
8
Driving Innovation
Our Investment (Assessment) criteria
Can the UK do it?
Is there a large market opportunity?
Is the idea ‘ready’?
Can the Technology Strategy Board make a
difference?
Model for success: a convincing “yes” to these 4 questions
9
Driving Innovation
Manufacturing Strategy
• Working with Industry
• Working with Academia
• Working with Government
• Working together
• Developing a common understanding of challenges and opportunities
• Prioritising investment in key areas
• Publish Strategy, launch CR&D competitions10
Driving Innovation
ManufacturingThrough Life
• Not just production
• Interfaces forwards and backwards
HIGH VALUE MANUFACTURING
Research
Design &Development
Production
Sale
Service
Operation
Decommission
11
Driving Innovation
We are world’s 6th largest manufacturer
12
Driving Innovation
ProductsProductionProcesses
ServiceSystems
Value Systems
The Four ‘Pillars’ of the HVM Strategy
The strategy includes key manufacturing activities that enhance competitive advantage in high wage economies;
…and it recognises that large amounts of value-add and value-capture occur outside production –
…and that technology may bring innovation in all areas.
13
Driving Innovation
Prioritisation .. in areas of high growth + high R&D intensity
Growth
R&
D I
nte
ns
ity
14
Driving Innovation
High Value Manufacturing Competition
• The Step Change in Competitiveness / Value Systems Competition was launched in January 2009 and invited businesses in a broad range of industry sectors to form consortia and compete for funding.
• The aim was for companies to achieve major improvements of between 25% and 50% relative to their current performance in areas such as overall manufacturing costs, whole life-cycle costs, whole life environmental impact and product performance, durability and reliability.
15
Driving Innovation
January 09 Competition - metrics
• £24M – Step Change in Competitiveness and Value Systems
• Your Response– 500 downloads (enquiries)– 300+ EoIs (>£300M investment requested)– 87 Full Proposals assessed– 32 projects shortlisted for funding
16
Driving Innovation
And the results – how the £24m was won
Sector/SIC Group Number of projects
TSB funding
(£m)
TSB Funding (%)
Bioscience & Healthcare 13 9.1 38
Special Purpose Machinery 8 4.9 20
Automotive 3 3.4 15
Aerospace 2 2.5 10
Electrical 1 1.1 5
Non Ferrous Metals 1 0.9 4
Construction 2 0.8 3
Agrochemicals 1 0.7 3
Environmental 1 0.6 3
Total 32 24 100 17
Driving Innovation
Some of the Winning Consortia – here today at NESTA
SHIELD Project
Simon Collins
Pete Ellison
Tom Pinto
Venu Kumar
BIOCHEMIST Project
Kay McClean
CELL THERAPIES Project
Tina Crombie
HEPTACORE Project
Mike Whelan
RAPIDPART Project
Russell Owen, Weir Valves
Peter Brown, TWI
STEP Project Keith Freebairn Professor Ian Sutherland
18
Driving Innovation
Discussion
• Consortia members – you are our customers !
• Customer satisfaction?
• How did you hear about the competition?
• Is the subject scope (technology) right for you?
• Funding and timescales?
• What do we (TSB & BIS) do right?
• What could we improve on?
• Other contributions & feedback?
19
Driving Innovation
SHIELD• Summary: The aim of project SHIELD is to develop novel acetabular and
femoral components that minimise bone resorption. This will be achieved through a combination of component design and material optimisation by which the load transfer from prosthesis to bone will attempt to mimic bone stress levels pre-operation. The objective is to develop an innovative solution to the problem of stress shielding in hip implants therefore increasing the efficacy of total hip prostheses by increased life span and a reduced need for revision surgery after failed implantation.
• Partners: – Corin Ltd (lead),
– Invibio Biomaterial Solutions Ltd,
– Durham University
– TWI Ltd,
– Imorphics Ltd,
– Continuum Blue Ltd.
20
Driving Innovation
BIOCHEMIST• Title: Biocatalysis and Chemical Engineering for Manufacturing Intensification
and Sustainability - BIOCHEMIST
• Summary: This project will integrate all phases of bioprocess development from catalyst discovery and engineering, to process design, through to highly efficient small footprint manufacture of high value products - enhancing the efficiency, sustainability and flexibility of chemical manufacture. The principle objectives of the project are (a) a novel compact reactor system for efficient continuous chemical manufacture, (b) advanced process design to accelerate introduction of new bio-manufacturing processes and products (c) new competitive bioprocesses to prepare unnatural amino acids and chiral amines.
• Partners: – C -Tech Innovation Ltd (lead),
– Ashe Morris Ltd,
– Ingenza Ltd.
21
Driving Innovation
STEP• Title: Scalable Technology for the Extraction of Pharmaceuticals - STEP
• Summary: We plan to develop small footprint, versatile, counter-current chromatography purification technology and methodology which can be operated at a range of scales in both batch and continuous modes and that can be inserted into existing process plant and systems. The consortium will address major production challenges aiming to provide a flexible, low capital capability driving substantial cost efficiency in both drug development and drug manufacturing processes.
• Partners: – GlaxoSmithKline Research and Development Ltd (lead)
– Brunel University
– Pfizer Limited
– Dynamic Extractions Ltd.
22
Driving Innovation
MANUFACTURE OF CELL THERAPIES• Title: Advanced manufacturing process for the production of individualised
cell therapies
• Summary: Individualised cell therapies ("ICTs") for the treatment of cancer, autoimmune disease, and infectious disease are progressing through regulatory approval for clinical use. ICTs are generally based on natural or genetically enhanced immune cells with disease-fighting applications and are therefore distinct from regenerative stem cell therapies. This project aims to achieve the first advanced cell manufacturing system (the "CellPro Manufacturing System") to support the routine clinical use of ICTs on a cost-effective and convenient basis.
• Partners: – Cell Medica Ltd (lead)
– University College London,
– eXmoor pharma concepts ltd.
23
Driving Innovation
RAPIDPART• Title: RapidPart - Significant Step Change in the Selective Laser Melting Powder
Bed Process for the Manufacture of High Value Components
• Summary: RapidPart will deliver step change reductions in the manufacturing cost of laser powder bed deposition, or Selective Laser Melting (SLM), by significantly increasing the speed of the process. The targeted 500% increase in processing speed will enable this high value, flexible and environmentally-friendly process to become commercially viable for a more widespread range of applications, giving the UK a technical advantage and world lead in laser additive manufacture.
• Partners: – Weir Valves and Controls UK Ltd (lead)
– TWI Ltd (Academic)
– Thinklaser Limited,
– MTT Technologies Ltd,
– SPI Lasers UK Limited
– Disenco Limited,
– Materialise UK.
24
Driving Innovation
HEPTACORE• Title: Commercial manufacture of a novel dual hepatitis vaccine
(Hepatacore)
• Summary: The aim of this project is the further development and commercial manufacture of a tandem-core technology (TCT) vaccine candidate, such that a clinical trial may be undertaken. TCT allows the insertion of at least two different viral antigens into a single highly immunogenic recombinant protein. This results in a vaccine which can deliver immunity to two viruses simultaneously within the confines of a single construct. This project intends to manufacture commercially a combined hepatitis A and B vaccine (HAV/HBV).
• Partners: – iQur Ltd
– University College London
– Mologic Ltd.
25
Driving Innovation
26
Driving Innovation
Helping you stay competitive
• Manufacturing Strategy– We believe our September 2008 HVM strategy
(and the Government’s Manufacturing Strategy published at the same time) remain valid and relevant, in recession and for recovery.
• Additional Funding– £150m Advanced Mfg package (July, Gov’t)– £5m extension to HVM competition (July, TSB)– £1m Technology Inspired Feasibility (Sept, TSB)– Further TSB competitions with significant
manufacturing content planned for 2010.
27